TerrAscend (TSNDF) Accounts Payables (2021 - 2026)
TerrAscend's (TSNDF) quarterly Accounts Payables came in at $40.0 million in Q1 2026, down 9.57% year-on-year from $44.2 million in Q1 2025, and little changed on a QoQ basis from $39.8 million in Q4 2025.
TerrAscend (TSNDF) Accounts Payables (2021 - 2026) Analysis & Trends
TerrAscend (TSNDF) has 6 years of Accounts Payables data on file, last reported at $40.0 million in Q1 2026.
- On a quarterly basis, Accounts Payables fell 9.57% year-over-year to $40.0 million in Q1 2026; TTM through Mar 2026 was $40.0 million, a 9.57% decrease from a year earlier, with the FY2025 full-year figure at $39.8 million, down 1.34% from the prior year.
- Accounts Payables for Q1 2026 stood at $40.0 million, roughly flat from $39.8 million in the prior quarter.
- Over the last five years, Accounts Payables for TSNDF reached as high as $61.7 million in Q3 2022 and fell as low as $36.0 million in Q3 2025.
- Historically, Accounts Payables has averaged $46.8 million across 5 years, with a median of $46.9 million in 2024.
- Across the five-year window, Accounts Payables soared 58.6% in 2022 and declined 22.4% in 2025, its largest moves.
- Year by year, Accounts Payables stood at $44.3 million in 2022, then increased by 12.67% to $49.9 million in 2023, then slipped by 19.14% to $40.3 million in 2024, then retreated by 1.34% to $39.8 million in 2025, then climbed by 0.43% to $40.0 million in 2026.
- Per Business Quant data, the three most recent Accounts Payables figures were $40.0 million in Q1 2026, $39.8 million in Q4 2025, and $36.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 4.96 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 2.60 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 507.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 3.13 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 498.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 1.67 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.75 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 773.00 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 372.00 Mn |
| 10 | TerrAscend | 160.44 Mn | 162.98 Mn | 34.60 Mn | 39.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 39.98 Mn |
| Dec 31, 2025 | 39.81 Mn |
| Sep 30, 2025 | 35.99 Mn |
| Jun 30, 2025 | 37.01 Mn |
| Mar 31, 2025 | 44.21 Mn |
| Dec 31, 2024 | 40.35 Mn |
| Sep 30, 2024 | 46.38 Mn |
| Jun 30, 2024 | 46.92 Mn |
| Mar 31, 2024 | 49.67 Mn |
| Dec 31, 2023 | 49.90 Mn |
| Sep 30, 2023 | 51.03 Mn |
| Jun 30, 2023 | 50.84 Mn |
| Mar 31, 2023 | 50.78 Mn |
| Dec 31, 2022 | 44.29 Mn |
| Sep 30, 2022 | 61.68 Mn |
| Jun 30, 2022 | 57.54 Mn |
| Mar 31, 2022 | 49.21 Mn |
| Dec 31, 2021 | 27.92 Mn |